Tech and healthcare-focused growth equity firm Silversmith Capital Partners has continued its breakneck fundraising pace by collecting $1.7bn for its new flagship fund - its fifth in the last ten ...

Healthcare investor Frazier Life Sciences has sealed a $1.3bn final close for its latest flagship fund, which will target company creation and early-stage private biopharmaceutical business.